Legal Representation
Attorney
Aaron D. Hendelman
USPTO Deadlines
Next Deadline
1775 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-06-11)
Due Date
June 11, 2030
Grace Period Ends
December 11, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
37 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jun 11, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
Jun 11, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
May 7, 2024 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
May 7, 2024 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
Apr 23, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Apr 23, 2024 | ALIE | A | ASSIGNED TO LIE | Loading... |
Apr 23, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Dec 4, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Sep 21, 2023 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
Sep 21, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Sep 21, 2023 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
Aug 20, 2023 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
Aug 20, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
Aug 10, 2023 | IUAF | S | USE AMENDMENT FILED | Loading... |
Aug 10, 2023 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
Aug 8, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Aug 4, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Aug 4, 2023 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Aug 4, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Feb 15, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Feb 13, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Feb 13, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Feb 13, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Aug 23, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Jun 28, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Jun 28, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Jun 8, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
May 19, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
May 11, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
May 11, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
May 11, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Apr 22, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Apr 22, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Apr 22, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Apr 21, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Feb 23, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Feb 21, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
First Use Anywhere:
Aug 2, 2022
First Use in Commerce:
Aug 2, 2022
Class 042
providing medical and scientific research information in the fields of pharmaceuticals and biotechnology
First Use Anywhere:
Aug 2, 2022
First Use in Commerce:
Aug 2, 2022
Classification
International Classes
005
042